MedTrace Logo

Development of a Silica Microparticle Taggant System to Measure ART Adherence

NCT06465862 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2026-04-28

No results posted yet for this study

Summary

Developing technologies to help measure and provide tools to support medication-taking behaviors (medication adherence) is an important step to ending the human immunodeficiency virus (HIV) epidemic. TruTag Technologies has pioneered the use of a microparticle system that can be incorporated into the coating of medications may help users both identify the medication they are taking and record adherence events. By using a standard smartphone camera, shining light on TruTag-coated medications automatically identifies them to an onboard smartphone app which then indirectly records the adherence event. This study evaluates the real-world usability and feasibility of operating this system among people living with HIV (PLWH).

Conditions

  • Hiv
  • Medication Adherence
  • Compliance, Medication

Interventions

DEVICE

TruTag System

TruTag technology system, consisting of microparticle-tagged Biktarvy and companion smartphone app.

DRUG

Biktarvy Pill

Biktarvy prescribed with TruTag system and tagged with TruTag microparticles.

Sponsors & Collaborators

  • Trutag Technologies

    collaborator UNKNOWN

  • Gilead Sciences

    collaborator INDUSTRY

  • Brigham and Women's Hospital

    lead OTHER

Principal Investigators

  • Peter R Chai, MD · Brigham and Women's Hospital

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-15
Primary Completion
2024-12-30
Completion
2025-04-15

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06465862 on ClinicalTrials.gov